Clinical Trial Update: Use of Pharmacogenetics to Select Erbitux or Cisplatin to Treat Head and Neck Cancer [NA]

View source ↗

Summary

This Georgetown University-sponsored trial evaluated pharmacogenetic-guided selection between cetuximab (Erbitux) and cisplatin for head and neck squamous cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• ERBITUX (cetuximab)

Snippet

Sponsor: Georgetown University | Conditions: Head and Neck Squamous Cell Cancer | NA | Status: TERMINATED | Results posted: 2014-10-02